FDA Inspection
Padagis US LLCPadagis US LLC – FDA Inspection, Oct 23, 2019
Record Details
This FDA Inspection record concerns Padagis US LLC, with an inspection on October 23, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Padagis US LLC
- Inspection Date
- October 23, 2019
- Product Type
- Drugs
View Company Profile
ID · a1a6211b-5744-41b0-a860-bdf1fb711a63
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1108752
- FDA center
- Human Drugs
- Project area
- Bioresearch Monitoring
Other FDA inspections of Padagis US LLC
11| Date | Classification | Office | Project area |
|---|---|---|---|
| April 8, 2026 | Not classified | Minneapolis District Office | Drug Quality Assurance |
| September 6, 2024 | VAI | Minneapolis District Office | Drug Quality Assurance |
| January 31, 2024 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 5, 2023 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| February 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Padagis US LLC
- FDA Inspection 1304064 - 2026-04-08
- FDA Inspection 1248645 - 2024-09-06
- FDA Inspection 1228870 - 2024-01-31
- FDA Inspection 1207462 - 2023-05-05
- FDA Inspection 1162776 - 2022-02-18
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.